Annual D&A:
$1.25M-$126.00K(-9.19%)Summary
- As of today, TSHA annual D&A is $1.25 million, with the most recent change of -$126.00 thousand (-9.19%) on December 31, 2024.
- During the last 3 years, TSHA annual D&A has risen by +$753.00 thousand (+153.05%).
- TSHA annual D&A is now -49.94% below its all-time high of $2.49 million, reached on December 31, 2022.
Performance
TSHA Depreciation & Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly D&A:
$286.00K+$9000.00(+3.25%)Summary
- As of today, TSHA quarterly D&A is $286.00 thousand, with the most recent change of +$9000.00 (+3.25%) on September 30, 2025.
- Over the past year, TSHA quarterly D&A has dropped by -$8000.00 (-2.72%).
- TSHA quarterly D&A is now -82.95% below its all-time high of $1.68 million, reached on December 31, 2022.
Performance
TSHA Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM D&A:
$1.15M-$8000.00(-0.69%)Summary
- As of today, TSHA TTM D&A is $1.15 million, with the most recent change of -$8000.00 (-0.69%) on September 30, 2025.
- Over the past year, TSHA TTM D&A has dropped by -$157.00 thousand (-12.01%).
- TSHA TTM D&A is now -57.12% below its all-time high of $2.68 million, reached on September 30, 2023.
Performance
TSHA TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TSHA Depreciation & Amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -9.2% | -2.7% | -12.0% |
| 3Y3 Years | +153.1% | +177.5% | +12.9% |
| 5Y5 Years | - | - | - |
TSHA Depreciation & Amortization Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -49.9% | +153.1% | -83.0% | +177.5% | -57.1% | +55.2% |
| 5Y | 5-Year | -49.9% | >+9999.0% | -83.0% | +177.5% | -57.1% | >+9999.0% |
| All-Time | All-Time | -49.9% | >+9999.0% | -83.0% | +177.5% | -57.1% | >+9999.0% |
TSHA Depreciation & Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | $286.00K(+3.2%) | $1.15M(-0.7%) |
| Jun 2025 | - | $277.00K(-2.1%) | $1.16M(-3.7%) |
| Mar 2025 | - | $283.00K(-6.9%) | $1.20M(-3.4%) |
| Dec 2024 | $1.25M(-9.2%) | $304.00K(+3.4%) | $1.25M(-4.7%) |
| Sep 2024 | - | $294.00K(-8.7%) | $1.31M(+76.4%) |
| Jun 2024 | - | $322.00K(-0.9%) | $741.00K(-30.4%) |
| Mar 2024 | - | $325.00K(-11.2%) | $1.06M(-22.3%) |
| Dec 2023 | $1.37M(-44.9%) | $366.00K(+234.6%) | $1.37M(-48.9%) |
| Sep 2023 | - | -$272.00K(-142.1%) | $2.68M(+3.8%) |
| Jun 2023 | - | $646.00K(+2.4%) | $2.58M(+1.4%) |
| Mar 2023 | - | $631.00K(-62.4%) | $2.55M(+2.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2022 | $2.49M(+405.5%) | $1.68M(+554.5%) | $2.49M(+144.1%) |
| Sep 2022 | - | -$369.00K(-160.5%) | $1.02M(-34.4%) |
| Jun 2022 | - | $610.00K(+7.2%) | $1.55M(+51.0%) |
| Mar 2022 | - | $569.00K(+172.2%) | $1.03M(+109.1%) |
| Dec 2021 | $492.00K(+5366.7%) | $209.00K(+25.9%) | $492.00K(+70.2%) |
| Sep 2021 | - | $166.00K(+95.3%) | $289.00K(+135.0%) |
| Jun 2021 | - | $85.00K(+165.6%) | $123.00K(+223.7%) |
| Mar 2021 | - | $32.00K(+433.3%) | $38.00K(+533.3%) |
| Dec 2020 | $9000.00 | - | - |
| Dec 2020 | - | $6000.00(>+9900.0%) | $6000.00(>+9900.0%) |
| Mar 2020 | - | $0.00 | $0.00 |
FAQ
- What is Taysha Gene Therapies, Inc. annual D&A?
- What is the all-time high annual D&A for Taysha Gene Therapies, Inc.?
- What is Taysha Gene Therapies, Inc. annual D&A year-on-year change?
- What is Taysha Gene Therapies, Inc. quarterly D&A?
- What is the all-time high quarterly D&A for Taysha Gene Therapies, Inc.?
- What is Taysha Gene Therapies, Inc. quarterly D&A year-on-year change?
- What is Taysha Gene Therapies, Inc. TTM D&A?
- What is the all-time high TTM D&A for Taysha Gene Therapies, Inc.?
- What is Taysha Gene Therapies, Inc. TTM D&A year-on-year change?
What is Taysha Gene Therapies, Inc. annual D&A?
The current annual D&A of TSHA is $1.25M
What is the all-time high annual D&A for Taysha Gene Therapies, Inc.?
Taysha Gene Therapies, Inc. all-time high annual D&A is $2.49M
What is Taysha Gene Therapies, Inc. annual D&A year-on-year change?
Over the past year, TSHA annual D&A has changed by -$126.00K (-9.19%)
What is Taysha Gene Therapies, Inc. quarterly D&A?
The current quarterly D&A of TSHA is $286.00K
What is the all-time high quarterly D&A for Taysha Gene Therapies, Inc.?
Taysha Gene Therapies, Inc. all-time high quarterly D&A is $1.68M
What is Taysha Gene Therapies, Inc. quarterly D&A year-on-year change?
Over the past year, TSHA quarterly D&A has changed by -$8000.00 (-2.72%)
What is Taysha Gene Therapies, Inc. TTM D&A?
The current TTM D&A of TSHA is $1.15M
What is the all-time high TTM D&A for Taysha Gene Therapies, Inc.?
Taysha Gene Therapies, Inc. all-time high TTM D&A is $2.68M
What is Taysha Gene Therapies, Inc. TTM D&A year-on-year change?
Over the past year, TSHA TTM D&A has changed by -$157.00K (-12.01%)